SMT201500196B - Derivati dell'acido idrossammico - Google Patents
Derivati dell'acido idrossammicoInfo
- Publication number
- SMT201500196B SMT201500196B SM201500196T SM201500196T SMT201500196B SM T201500196 B SMT201500196 B SM T201500196B SM 201500196 T SM201500196 T SM 201500196T SM 201500196 T SM201500196 T SM 201500196T SM T201500196 B SMT201500196 B SM T201500196B
- Authority
- SM
- San Marino
- Prior art keywords
- acid derivatives
- hydroxamic acid
- hydroxamic
- derivatives
- acid
- Prior art date
Links
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0013—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14700209P | 2009-01-23 | 2009-01-23 | |
| US15649609P | 2009-02-28 | 2009-02-28 | |
| US25215609P | 2009-10-15 | 2009-10-15 | |
| US25265209P | 2009-10-17 | 2009-10-17 | |
| PCT/US2010/020373 WO2010085377A2 (en) | 2009-01-23 | 2010-01-07 | Hydroxamic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201500196B true SMT201500196B (it) | 2015-10-30 |
Family
ID=42356377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201500196T SMT201500196B (it) | 2009-01-23 | 2015-08-13 | Derivati dell'acido idrossammico |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US8609864B2 (enExample) |
| EP (1) | EP2389375B1 (enExample) |
| JP (1) | JP5576402B2 (enExample) |
| CN (1) | CN102186842B (enExample) |
| CA (1) | CA2750413C (enExample) |
| CY (1) | CY1116602T1 (enExample) |
| DK (1) | DK2389375T3 (enExample) |
| ES (1) | ES2544803T3 (enExample) |
| HR (1) | HRP20150778T1 (enExample) |
| HU (1) | HUE025349T2 (enExample) |
| ME (1) | ME02254B (enExample) |
| PL (1) | PL2389375T3 (enExample) |
| PT (1) | PT2389375E (enExample) |
| RS (1) | RS54192B1 (enExample) |
| SI (1) | SI2389375T1 (enExample) |
| SM (1) | SMT201500196B (enExample) |
| WO (1) | WO2010085377A2 (enExample) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR070228A1 (es) | 2008-01-22 | 2010-03-25 | Dow Agrosciences Llc | Derivados de 5-fluoro pirimidina |
| ME02254B (me) * | 2009-01-23 | 2015-12-31 | Euro Celtique Sa | Derivati hidroksamske kiseline |
| UA112284C2 (uk) | 2009-08-07 | 2016-08-25 | ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі | Похідні 5-фторпіримідинону |
| UA107671C2 (en) * | 2009-08-07 | 2015-02-10 | Dow Agrosciences Llc | N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives |
| AU2010279411B2 (en) | 2009-08-07 | 2014-10-23 | Adama Makhteshim Ltd. | N1-sulfonyl-5-fluoropyrimidinone derivatives |
| UA106889C2 (uk) | 2009-08-07 | 2014-10-27 | ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі | Похідні n1-ацил-5-фторпіримідинону |
| RU2547721C2 (ru) | 2010-01-07 | 2015-04-10 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | ТИАЗОЛО [5, 4-d] ПИРИМИДИНЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ АГРОХИМИЧЕСКИХ СРЕДСТВ |
| CN101928234B (zh) * | 2010-01-15 | 2012-12-12 | 北京欧凯纳斯科技有限公司 | 6/7-（杂）芳基-n-羟基己/庚酰胺化合物及其制备方法 |
| WO2011113175A1 (zh) * | 2010-03-15 | 2011-09-22 | Gao Feng | 阿糖胞苷前药衍生物及其在抗癌抗肿瘤中的用途 |
| WO2012096832A2 (en) * | 2011-01-12 | 2012-07-19 | Crystal Biopharmaceutical Llc | Hdac inhibiting derivatives of camptothecin |
| HUE035248T2 (en) | 2011-08-17 | 2018-05-02 | Adama Makhteshim Ltd | 1-Substituted-5-fluoro-3,6-dihydro-6-imino-2 (1H) -pyrimidinone derivatives as fungicidal compositions for use in plant protection |
| CN102993102B (zh) * | 2011-09-16 | 2016-08-24 | 杭州民生药业有限公司 | [1-甲基-2-(7’-庚异羟肟酸基)-5-n，n-二(2’-氯乙基)]-1h-苯并咪唑的合成方法 |
| EP2758052B9 (en) * | 2011-09-18 | 2019-03-27 | Euro-Celtique S.A. | Pharmaceutical composition comprising an HDAC inhibitor and a cyclopolysaccharide |
| CN102432654A (zh) * | 2011-09-26 | 2012-05-02 | 宋云龙 | 吉西他滨酰胺衍生物及其制备方法和用途 |
| TWI573792B (zh) | 2012-02-01 | 2017-03-11 | 歐陸斯迪公司 | 新穎治療劑 |
| CN102584737A (zh) * | 2012-02-07 | 2012-07-18 | 盛世泰科生物医药技术(苏州)有限公司 | 抑制组蛋白去乙酰酶的物质的组成和使用 |
| EP2725029A1 (en) * | 2012-10-29 | 2014-04-30 | Laboratoire Biodim | New antibacterial compounds and biological applications thereof |
| HUE047711T2 (hu) | 2012-12-28 | 2020-05-28 | Adama Makhteshim Ltd | N-(szubsztituált)-5-fluor-4-imino-3-metil-2-oxo-3,4-dihidropirimidin-1(2H)-karboxilát származékok |
| UA117123C2 (uk) | 2012-12-28 | 2018-06-25 | Адама Махтешім Лтд. | Похідні 1-(заміщений бензоїл)-5-фтор-4-іміно-3-метил-3,4-дигідропіримідин-2(1h)-ону |
| RU2015131149A (ru) | 2012-12-28 | 2017-02-03 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | N-(замещенные)-5-фтор-4-имино-3-метил-2-оксо-3,4-дигидропиримидин-1(2н)-карбоксамидные производные |
| CA2894553C (en) | 2012-12-31 | 2021-03-02 | Dow Agrosciences Llc | 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1h)-one derivatives as fungicides |
| CN103340845B (zh) * | 2013-06-26 | 2015-03-18 | 浙江省食品药品检验研究院 | 药物组合物 |
| EP3078671A4 (en) * | 2013-12-04 | 2017-05-31 | Hangzhou Minsheng Institutes for Pharma Research Co., Ltd. | Gemcitabine derivative, composition containing the derivative and pharmaceutical use of the derivative |
| EP3097096A4 (en) | 2013-12-31 | 2017-10-11 | Adama Makhteshim Ltd. | 5-fluoro-4-imino-3-(alkyl/substituted alkyl)-1- (arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one and processes for their preparation |
| EA030030B1 (ru) | 2013-12-31 | 2018-06-29 | Адама Мактешим Лтд. | Синергетические фунгицидные смеси и синергетические фунгицидные композиции для борьбы с грибами |
| CA2934902C (en) | 2014-02-03 | 2018-08-14 | Halliburton Energy Services, Inc. | Geomechanical and geophysical computational model for oil and gas stimulation and production |
| GB201409485D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB201409488D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB201409471D0 (en) * | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| CN107108521A (zh) * | 2014-10-28 | 2017-08-29 | 盐野义制药株式会社 | 具有ampk活化作用的杂环衍生物 |
| MY195058A (en) | 2015-05-22 | 2023-01-05 | Chong Kun Dang Pharmaceutical Corp | Heterocyclicalkyl Derivative Compounds as Selective Histone Deacetylase Inhibitors and Pharmaceutical Compositions Comprising the Same |
| CN108348780A (zh) | 2015-09-10 | 2018-07-31 | 贝克顿·迪金森公司 | 用作用于环磷酰胺和异环磷酰胺的免疫分析的免疫原和分析缀合物的环磷酰胺类似物 |
| WO2018068832A1 (en) | 2016-10-11 | 2018-04-19 | Euro-Celtique S.A. | Hodgkin lymphoma therapy |
| CN106905191B (zh) * | 2017-03-05 | 2019-03-29 | 北京化工大学 | 一种含有羟肟酸基团的氮芥类化合物及其制备方法和用途 |
| CN106883217B (zh) * | 2017-04-01 | 2020-05-22 | 清华大学深圳研究生院 | 一种核苷碱基异羟肟酸衍生化合物及其制备方法与应用 |
| GB201709402D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating t-pll |
| GB201709405D0 (en) * | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating ovarian cancer |
| GB201709403D0 (en) * | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating sarcoma |
| GB201709406D0 (en) | 2017-06-13 | 2017-07-26 | Euro-Cletique S A | Compounds for treating TNBC |
| CA3071345A1 (en) * | 2017-07-28 | 2019-01-31 | Yale University | Anticancer drugs and methods of making and using same |
| CN111107939B (zh) | 2017-09-21 | 2022-04-12 | 贝克顿·迪金森公司 | 引导有害污染物样品的收集的系统和模板及使用其的方法 |
| USD859683S1 (en) | 2017-09-21 | 2019-09-10 | Becton, Dickinson And Company | Collection device |
| JP7223749B2 (ja) | 2017-09-21 | 2023-02-16 | ベクトン・ディキンソン・アンド・カンパニー | 危険汚染物質の試験における高ダイナミックレンジの分析器 |
| EP3684944B1 (en) | 2017-09-21 | 2025-01-01 | Becton, Dickinson and Company | Hazardous contaminant collection kit and rapid testing |
| CN108299313B (zh) * | 2018-01-16 | 2020-10-02 | 长沙霍滋生物科技有限公司 | 一种化合物及其在药学上的应用 |
| CN109516957A (zh) * | 2018-08-03 | 2019-03-26 | 杭州梯诺医药科技有限公司 | Nl-101多晶型及其制备方法 |
| SG11202100411TA (en) * | 2018-08-03 | 2021-02-25 | Cellix Bio Private Ltd | Compositions and methods for the treatment of cancer |
| JP7180923B2 (ja) * | 2018-09-01 | 2022-11-30 | ベイジン ショウバイ ファーマシューティカル カンパニー，リミティッド | 白金系化合物リン酸塩及びその製造方法 |
| EP3897626B1 (en) | 2018-12-18 | 2025-09-10 | Mundipharma International Corporation Limited | Tinostamustine for treating multiple myeloma |
| CN113383222A (zh) | 2019-01-28 | 2021-09-10 | 贝克顿·迪金森公司 | 具有集成的拭子和测试装置的有害污染物收集装置 |
| CN112209884B (zh) * | 2019-07-12 | 2022-11-11 | 杭州梯诺医药科技有限公司 | 1-h苯并咪唑衍生物、制备方法及其应用 |
| CN113307829B (zh) * | 2021-05-08 | 2022-05-24 | 苏州科技大学 | 一种以异羟肟酸衍生物为配体的铂(ii)配合物及其制备方法和应用 |
| JP2026517851A (ja) | 2023-05-05 | 2026-06-02 | ユーロ－セルティーク エス．エイ． | がんを処置するための組合せ |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5369108A (en) | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
| CA2423868C (en) | 2000-09-29 | 2011-06-07 | Prolifix Limited | Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| CA2561617A1 (en) | 2004-04-05 | 2005-10-20 | Aton Pharma, Inc. | Histone deacetylase inhibitor prodrugs |
| WO2007134169A2 (en) | 2006-05-10 | 2007-11-22 | Nuada, Llc | Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof |
| US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| GB0621160D0 (en) | 2006-10-24 | 2006-12-06 | Imp College Innovations Ltd | Compounds and uses thereof |
| US8987468B2 (en) * | 2008-02-04 | 2015-03-24 | The Translational Genomics Research Institute | Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives |
| ME02254B (me) * | 2009-01-23 | 2015-12-31 | Euro Celtique Sa | Derivati hidroksamske kiseline |
-
2010
- 2010-01-07 ME MEP-2015-541A patent/ME02254B/me unknown
- 2010-01-07 SI SI201030986T patent/SI2389375T1/sl unknown
- 2010-01-07 CN CN201080002890.XA patent/CN102186842B/zh active Active
- 2010-01-07 PT PT107337479T patent/PT2389375E/pt unknown
- 2010-01-07 EP EP20100733747 patent/EP2389375B1/en active Active
- 2010-01-07 WO PCT/US2010/020373 patent/WO2010085377A2/en not_active Ceased
- 2010-01-07 RS RS20150541A patent/RS54192B1/sr unknown
- 2010-01-07 CA CA2750413A patent/CA2750413C/en active Active
- 2010-01-07 HU HUE10733747A patent/HUE025349T2/en unknown
- 2010-01-07 ES ES10733747.9T patent/ES2544803T3/es active Active
- 2010-01-07 PL PL10733747T patent/PL2389375T3/pl unknown
- 2010-01-07 JP JP2011547997A patent/JP5576402B2/ja active Active
- 2010-01-07 DK DK10733747.9T patent/DK2389375T3/en active
- 2010-01-07 US US13/143,155 patent/US8609864B2/en not_active Ceased
- 2010-01-07 US US14/972,750 patent/USRE46144E1/en active Active
- 2010-01-07 HR HRP20150778TT patent/HRP20150778T1/hr unknown
-
2013
- 2013-11-08 US US14/075,145 patent/US9096627B2/en active Active
-
2015
- 2015-08-13 SM SM201500196T patent/SMT201500196B/xx unknown
- 2015-08-13 CY CY20151100709T patent/CY1116602T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2389375A2 (en) | 2011-11-30 |
| HUE025349T2 (en) | 2016-02-29 |
| US20140066419A1 (en) | 2014-03-06 |
| JP5576402B2 (ja) | 2014-08-20 |
| CN102186842A (zh) | 2011-09-14 |
| PT2389375E (pt) | 2015-09-17 |
| US20110269706A1 (en) | 2011-11-03 |
| USRE46144E1 (en) | 2016-09-13 |
| RS54192B1 (sr) | 2015-12-31 |
| DK2389375T3 (en) | 2015-08-24 |
| HRP20150778T1 (hr) | 2015-08-28 |
| ME02254B (me) | 2015-12-31 |
| EP2389375A4 (en) | 2012-09-19 |
| PL2389375T3 (pl) | 2015-11-30 |
| US9096627B2 (en) | 2015-08-04 |
| CY1116602T1 (el) | 2018-03-07 |
| JP2012515776A (ja) | 2012-07-12 |
| US8609864B2 (en) | 2013-12-17 |
| CA2750413C (en) | 2016-06-21 |
| WO2010085377A2 (en) | 2010-07-29 |
| CA2750413A1 (en) | 2010-07-29 |
| CN102186842B (zh) | 2014-07-23 |
| ES2544803T3 (es) | 2015-09-04 |
| SI2389375T1 (sl) | 2015-11-30 |
| WO2010085377A3 (en) | 2011-03-31 |
| EP2389375B1 (en) | 2015-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2011000086A (es) | Derivados de acido 1-amino-2-ciclobutiletilboronico | |
| SMT201600198B (it) | Derivati di 1,2,4-triazina-4-ammina | |
| DK2623507T3 (da) | Morpholinonukleinsyrederivat | |
| DK2562155T3 (da) | Hydroxaminsyrederivat | |
| EP2398483A4 (en) | Oxyntomodulin Analogs | |
| FI20095678A0 (fi) | Ureasubstituoituja sulfoniamidijohdannaisia | |
| EP2552216A4 (en) | DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID | |
| DK2361256T3 (da) | Cyclohexenyl-nukleinsyreanaloger | |
| SMT201500053B (it) | 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori | |
| EP2704573A4 (en) | AMINOMETHYL biaryl BENZOTRIAZOL DERIVATIVES | |
| DK2421808T3 (da) | 4-Hydroxysmørsyreanaloger | |
| EP2281080A4 (en) | POLYLACTIC ACID FIBERS | |
| BRPI1009315A2 (pt) | agentes anti-inflamatórios | |
| LT3061445T (lt) | Labai koncentruotos farmacinės kompozicijos | |
| ECSP12011999A (es) | Derivados benzamida sustituidos | |
| BR112013002925A2 (pt) | processo para a síntese de ácido 2,5-furandicarboxílico | |
| BR112012004593A2 (pt) | "método" | |
| EP2389375A4 (en) | Hydroxamic acid derivatives | |
| BRPI0810660A2 (pt) | Derivados do ácido lipóico | |
| DK2397480T3 (da) | Diazepindionderivat | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| EP2721029A4 (en) | Imidazopyridine-2-ON DERIVATIVES | |
| DK2387580T3 (da) | Deoxyactagardinderivater | |
| BRPI1010778A2 (pt) | "escada dupla" | |
| BR112012028007A2 (pt) | composição aquosa |